These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24417752)

  • 1. Troglitazone metabolism and transporter effects in chimeric mice: a comparison between chimeric humanized and chimeric murinized FRG mice.
    Samuelsson K; Pickup K; Sarda S; Foster JR; Randall K; Abrahamsson A; Jacobsen M; Weidolf L; Wilson I
    Xenobiotica; 2014 Jan; 44(2):186-95. PubMed ID: 24417752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.
    Schulz-Utermoehl T; Sarda S; Foster JR; Jacobsen M; Kenna JG; Morikawa Y; Salmu J; Gross G; Wilson ID
    Xenobiotica; 2012 Jun; 42(6):503-17. PubMed ID: 22201515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and xenobiotic metabolite profiling of liver extracts from SCID and chimeric humanized mice following repeated oral administration of troglitazone.
    Barnes AJ; Baker DR; Hobby K; Ashton S; Michopoulos F; Spagou K; Loftus NJ; Wilson ID
    Xenobiotica; 2014 Jan; 44(2):174-85. PubMed ID: 24350779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.
    Foster JR; Jacobsen M; Kenna G; Schulz-Utermoehl T; Morikawa Y; Salmu J; Wilson ID
    Toxicol Pathol; 2012 Dec; 40(8):1106-16. PubMed ID: 22673116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and metabolism of diclofenac in chimeric humanized and murinized FRG mice.
    Wilson CE; Dickie AP; Schreiter K; Wehr R; Wilson EM; Bial J; Scheer N; Wilson ID; Riley RJ
    Arch Toxicol; 2018 Jun; 92(6):1953-1967. PubMed ID: 29721588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats.
    Kostrubsky VE; Vore M; Kindt E; Burliegh J; Rogers K; Peter G; Altrogge D; Sinz MW
    Drug Metab Dispos; 2001 Dec; 29(12):1561-6. PubMed ID: 11717175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation.
    Lee JK; Marion TL; Abe K; Lim C; Pollock GM; Brouwer KL
    J Pharmacol Exp Ther; 2010 Jan; 332(1):26-34. PubMed ID: 19801447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma concentration-time profiles of troglitazone and troglitazone sulfate simulated by in vivo experiments with chimeric mice with humanized livers and semi-physiological pharmacokinetic modeling.
    Ito S; Kamimura H; Yamamoto Y; Chijiwa H; Okuzono T; Suemizu H; Yamazaki H
    Drug Metab Pharmacokinet; 2020 Dec; 35(6):505-514. PubMed ID: 32962912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and metabolism of lumiracoxib in chimeric humanized and murinized FRG mice.
    Dickie AP; Wilson CE; Schreiter K; Wehr R; Wilson EM; Bial J; Scheer N; Wilson ID; Riley RJ
    Biochem Pharmacol; 2017 Jul; 135():139-150. PubMed ID: 28351678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatocytes can repopulate mouse liver: histopathology of the liver in human hepatocyte-transplanted chimeric mice and toxicologic responses to acetaminophen.
    Sato Y; Yamada H; Iwasaki K; Tateno C; Yokoi T; Yoshizato K; Horii I
    Toxicol Pathol; 2008 Jun; 36(4):581-91. PubMed ID: 18467679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Engraftment of Human Hepatocytes in uPA-SCID and FRG
    Foquet L; Wilson EM; Verhoye L; Grompe M; Leroux-Roels G; Bial J; Meuleman P
    Methods Mol Biol; 2017; 1506():117-130. PubMed ID: 27830549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury.
    Kakuni M; Morita M; Matsuo K; Katoh Y; Nakajima M; Tateno C; Yokoi T
    Toxicol Lett; 2012 Oct; 214(1):9-18. PubMed ID: 22902350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone.
    Yokoi T
    Handb Exp Pharmacol; 2010; (196):419-35. PubMed ID: 20020270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.
    Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K
    Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next?
    Yoshizato K; Tateno C
    Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1419-35. PubMed ID: 23978259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Prediction of OATP-Mediated Disposition and Biliary Clearance Using Human Liver Chimeric Mice.
    Miyake T; Tsutsui H; Hirabayashi M; Tachibana T
    J Pharmacol Exp Ther; 2023 Nov; 387(2):135-149. PubMed ID: 37142442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of chimeric mice with humanized liver for study of human-specific drug metabolism.
    Bateman TJ; Reddy VG; Kakuni M; Morikawa Y; Kumar S
    Drug Metab Dispos; 2014 Jun; 42(6):1055-65. PubMed ID: 24700822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9-catalyzed metabolism of S-warfarin to 7-hydroxywarfarin in vivo and in vitro in chimeric mice with humanized liver.
    Inoue T; Nitta K; Sugihara K; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2008 Dec; 36(12):2429-33. PubMed ID: 18784266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of conjugation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures.
    Kostrubsky VE; Sinclair JF; Ramachandran V; Venkataramanan R; Wen YH; Kindt E; Galchev V; Rose K; Sinz M; Strom SC
    Drug Metab Dispos; 2000 Oct; 28(10):1192-7. PubMed ID: 10997939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of troglitazone, an antidiabetic agent: prediction of in vivo stereoselective sulfation and glucuronidation from in vitro data.
    Izumi T; Hosiyama K; Enomoto S; Sasahara K; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1392-400. PubMed ID: 9067328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.